NDC 72516-012 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 5 mg/1; Amphetamine Aspartate Monohydrate 5 mg/1; Dextroamphetamine Sulfate 5 mg/1; Amphetamine Sulfate 5 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC72516-012

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
Oryza Pharmaceuticals Inc.
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA210293
Marketed since
October 19, 2020
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
72516-012-01100 TABLET in 1 BOTTLE (72516-012-01)Oct 19, 2020

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products